Skip to Content
Merck
CN

47437

Fmoc-D-Tic-OH

≥98.0% (TLC)

Synonym(s):

(R)-N-Fmoc-1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid

Sign In to View Organizational & Contract Pricing.

Select a Size

About This Item

Empirical Formula (Hill Notation):
C25H21NO4
CAS Number:
130309-33-0
Molecular Weight:
399.44
PubChem Substance ID:
57650954
UNSPSC Code:
12352200
Beilstein/REAXYS Number:
7499344
MDL number:
MFCD00144345

Key Documents

View All Documentation
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist

SMILES string

OC(=O)[C@H]1Cc2ccccc2CN1C(=O)OCC3c4ccccc4-c5ccccc35

InChI

1S/C25H21NO4/c27-24(28)23-13-16-7-1-2-8-17(16)14-26(23)25(29)30-15-22-20-11-5-3-9-18(20)19-10-4-6-12-21(19)22/h1-12,22-23H,13-15H2,(H,27,28)/t23-/m1/s1

InChI key

LIRBCUNCXDZOOU-HSZRJFAPSA-N

assay

≥98.0% (TLC)

optical activity

[α]20/D −25.0±2°, c = 0.6% in methanol

application(s)

peptide synthesis

functional group

Fmoc

storage temp.

2-8°C

Other Notes

FMOC-D-Tic is employed e.g. for the solid-phase synthesis of Bradykinin antagonists

Storage Class

13 - Non Combustible Solids

wgk

WGK 3

flash_point_f

Not applicable

flash_point_c

Not applicable

ppe

Eyeshields, Gloves, type N95 (US)

Regulatory Information

新产品
This item has

Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number
413083/1

Don't see the Right Version?

If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

Search for a COA

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

C Thurieau et al.
Journal of medicinal chemistry, 39(10), 2095-2101 (1996-05-10)
We report here on the synthesis and pharmacological properties of a new series of small linear and cyclic peptides derived from the five C-terminal amino acid residues of second-generation bradykinin receptor antagonists. Variations of the two first residues of the
V S Goodfellow et al.
Journal of medicinal chemistry, 39(7), 1472-1484 (1996-03-29)
We report a systematic probing of the structural requirements of the bradykinin (BK) type 2 (B(2)) receptor for antagonist activity by incorporating N-alkyl-amino acid residues at positions 7 and 8 of a potent antagonist sequence. Compound 1 (D-Arg(0)-Arg(1)-Pro(2)-Hyp(3)-Gly(4)-Thi(5)-Ser(6)-D-Tic(7)-N-Chg (8)-Arg(9), CP-0597)(1,2)

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service